Exane Derivatives’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Exane Derivatives’s Portfolio KNSA Stock Details KNSA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$92K	Hold
2022 Q1	$94.4K	Sell
2021 Q4	$121K	Sell
2021 Q3	$123K	Buy
2021 Q2	$131K	Buy
2021 Q1	$121K	Sell
2020 Q4	$139K	Buy
2020 Q3	$80.9K	Buy
2020 Q2	$108K	Sell
2020 Q1	$91.2K	Buy